Procurement Summary
Country : USA
Summary : Improving Predictability of Food-drug and Drug-drug Interaction Risks by Utilizing in Vitro Simulated Gastrointestinal Dissolution Model for High-risk Oral Drug Products (u01) Clinical Trial Optional
Deadline : 31 Mar 2024
Other Information
Notice Type : Tender
TOT Ref.No.: 95298310
Document Ref. No. : RFA-FD-24-009
Competition : ICB
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : USD 250000
Purchaser's Detail
Purchaser : FOOD AND DRUG ADMINISTRATION
Terrin Brown Grantor Phone 2404027610
USA
URL :https://www.grants.gov/search-grants
Tender Details
The Purpose Of This Funding Opportunity Is To Examine The Utility Of An In Vitro Simulated Gastrointestinal (Gi) Dissolution Model For The Assessment Of In Vitro Performance Of Amorphous Solid Dispersion (Asd) Drug Products Under Different Clinically Relevant Conditions. The Goal Is To Develop And Validate The In Vitro Mechanistic Methodology To Provide An Improved Understanding Of Impact Of Food And Acid Reducing Agents On The Absorption For Test And Reference Listed Drug (Rld) Drug Products, T...
Opportunity Category : Discretionary
Opportunity Category Explanation :
Funding Instrument Type : Cooperative Agreement
Category of Funding Activity : AgricultureConsumer ProtectionFood and Nutrition
CFDA_Number : 93.103 -- Food and Drug Administration Research
Award_Ceiling : 250000
Posted Date : Jan 15, 2024
Last Updated Date : Jan 15, 2024
Documents
Tender Notice